Examines legislative proposals to promote the development of bioterrorism countermeasures by private companies, including Project BioShield, a proposal to encourage development of vaccines and treatments for potential bioterrorism agents such as anthrax and smallpox. Describes provisions of P.L. 108-276, the Project BioShield Act of 2004, and reviews policy issues.
ProQuest U.S. Congressional Research Digital Collection
Note:
Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. AVAILABLE ONLINE TO AUTHORIZED PSU USERS.
